Drooling, dysphagia and upper-aerodigestive disorders — branching viva

Opening

Examiner: A 7-year-old with severe cerebral palsy is in your neurodisability clinic. He has persistent drooling that soaks several bibs a day and has caused perioral skin breakdown, and he has had three lower-respiratory infections this year. His parents say mealtimes take over an hour and he coughs on thin fluids. Tell me what is going on and what you will do first. [5]

Candidate: This child has two overlapping problems that share one mechanism — oromotor impairment. The drooling is problematic, but the more urgent concern is the posterior drooling and an unsafe swallow suggested by coughing on thin fluids and recurrent chest infections. I would think of this as one upper-aerodigestive system: can he move saliva and food safely to the stomach without soiling the airway? My first step is to assess the swallow formally and protect the airway, while addressing the drooling in a stepwise way. [5] [9]

Branch 1 — mechanism of drooling

Examiner: So is he making too much saliva? [5]

Candidate: No — that is the common misconception. Drooling in cerebral palsy is almost always a clearance problem, not overproduction. Children with neurodisability produce similar or smaller volumes of saliva than their peers; the drooling comes from poor lip seal, discoordinated and infrequent swallowing, reduced oral sensory awareness and poor head and trunk control. That matters because it directs management toward improving clearance and posture, and toward reducing saliva only when clearance cannot keep up — rather than assuming the glands are overactive. [5]

Examiner (probe): Why are the chest infections relevant to the drooling? [9]

Candidate: Because the dangerous drooling is posterior drooling. When pooled saliva is cleared backward rather than forward, it spills over the back of the tongue into the pharynx and, in a child whose pharyngeal swallow is already impaired, is aspirated. And aspiration in neurodisability is often silent — no protective cough — so the first sign is recurrent chest infections rather than dramatic choking. A damp chin is a social problem; a soiled airway is a respiratory one. [9]

Branch 2 — assessing the swallow

Examiner: How would you confirm whether his swallow is unsafe? [7]

Candidate: I would start with a clinical swallow evaluation by a speech-language therapist — observing oral structures, tone and sensation, bolus control, swallow timing and coordination, and the voice quality and breathing after the swallow. That raises and ranks suspicion, but it cannot reliably detect silent aspiration, so if the swallow is in doubt I would do an instrumental study. The videofluoroscopic swallow study is the reference test: it assesses all four phases, directly visualises penetration and aspiration including the silent form, and lets me test compensations — texture, posture, bolus size — on the spot. FEES is a bedside complement that assesses the pharyngeal phase and secretion management. [7]

Examiner (probe): VFSS or FEES — when would you choose one over the other? [7]

Candidate: VFSS when I need the whole swallow and want to test compensations; FEES when I want bedside monitoring of secretion management and pooling without radiation, or when the child cannot cooperate with fluoroscopy. They are complementary rather than interchangeable, and the choice depends on the question I am asking. [7]

Branch 3 — the drooling ladder

Examiner: Assuming the swallow can be made safe, walk me through how you would manage the drooling. [1]

Candidate: I would climb the ladder and step up only as far as needed. First, non-pharmacological measures — optimise posture and head control, treat nasal obstruction and mouth breathing, maintain oral hygiene and dental care, and protect the skin. Second, oromotor and swallow therapy from speech-language therapy. Because those have had limited effect here, I would step to pharmacological saliva reduction with glycopyrrolate (glycopyrronium) orally — the best-studied first-line anticholinergic, weight-based and titrated. I would get a baseline swallow and chest assessment and repeat it, because anticholinergics thicken secretions and can paradoxically worsen swallow and airway clearance. If that is insufficient or not tolerated, botulinum toxin into the submandibular and parotid glands reduces saliva for around three to four months and is repeatable; surgery — submandibular duct relocation, with or without gland excision — is reserved for refractory or posterior disease. [1] [2]

Examiner (probe): He comes back in six weeks on glycopyrrolate with two chest infections and a wetter-sounding swallow. What do you do? [1]

Candidate: The drug has thickened his secretions and worsened his swallow and airway clearance. I would review the swallow and chest together and reduce or stop the glycopyrrolate — this is exactly why I monitor these children. I would treat the acute infection and reconsider the saliva strategy, possibly moving to botulinum toxin or surgery if ongoing reduction is needed, while prioritising the airway. [1] [9]

Close

Examiner: Summarise your safe approach in one line. [5]

Candidate: Treat drooling, dysphagia and aspiration as one system: separate anterior from posterior drooling, assess the swallow clinically and instrumentally when in doubt, and step up the drooling ladder from therapy and posture through glycopyrrolate and botulinum toxin to surgery — always treating the wet lung as readily as the wet chin, monitoring anticholinergics for thickened secretions, and reserving oesophagogastric dissociation for the airway that cannot otherwise be protected. [1] [9]